** Shares of WuXi Biologics (Cayman) Inc 2269.HK drop 7.3% to HK$25.95, on track for the biggest one-day pct fall since April 7
** Stock hits the lowest since June 10, and on course to snap five consecutive sessions of gain
** Top pct loser on Hang Seng Biotech Index .HSHKBIO, which gains 0.5%
** The biologics discovery, development and manufacturing group said key shareholder WuXi Biologics Holdings plans sale of 2.04% stake for HK$2.21 bln ($281.55 mln) in share placement, reducing its stake in the firm to 12.32% from 14.36%
** The key shareholder plans sale of 82.94 mln existing shares at HK$26.60 each, or 5% discount to Friday's close of HK$28 each
** Hong Kong's healthcare index .HSCIH adds 0.3%, while Hang Seng Index .HSI slips 0.4%
** YTD, stock up 51.8% YTD
($1 = 7.8494 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。